HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by First National Bank of Mount Dora Trust Investment Services

First National Bank of Mount Dora Trust Investment Services boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,043 shares of the company's stock after purchasing an additional 956 shares during the quarter. First National Bank of Mount Dora Trust Investment Services' holdings in HCA Healthcare were worth $3,125,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Principal Financial Group Inc. boosted its holdings in shares of HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock worth $262,264,000 after purchasing an additional 476,756 shares during the period. Brighton Jones LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $1,021,000. ABC Arbitrage SA purchased a new position in shares of HCA Healthcare in the fourth quarter worth $1,511,000. OLD National Bancorp IN lifted its stake in HCA Healthcare by 5.2% during the 1st quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock valued at $362,000 after acquiring an additional 52 shares during the period. Finally, Savant Capital LLC grew its position in HCA Healthcare by 4.1% during the fourth quarter. Savant Capital LLC now owns 3,673 shares of the company's stock valued at $1,102,000 after buying an additional 146 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

HCA traded up $2.27 on Wednesday, hitting $367.19. 1,026,667 shares of the company traded hands, compared to its average volume of 1,449,044. The company has a 50 day moving average of $356.11 and a 200-day moving average of $332.28. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a market capitalization of $88.34 billion, a PE ratio of 16.71, a PEG ratio of 1.10 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the previous year, the company earned $5.36 EPS. The company's quarterly revenue was up 5.7% on a year-over-year basis. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is currently 12.81%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Guggenheim assumed coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Robert W. Baird reissued a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $392.47.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.